Celastrol Attenuates Psoriasiform Inflammation by Targeting the IRF1/GSTM3 Axis

J Invest Dermatol. 2022 Aug;142(8):2281-2285.e11. doi: 10.1016/j.jid.2022.01.018. Epub 2022 Feb 5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glutathione Transferase
  • Humans
  • Inflammation / drug therapy
  • Interferon Regulatory Factor-1
  • Pentacyclic Triterpenes
  • Psoriasis* / drug therapy
  • Triterpenes* / pharmacology
  • Triterpenes* / therapeutic use

Substances

  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • Pentacyclic Triterpenes
  • Triterpenes
  • GSTM3 protein, human
  • Glutathione Transferase
  • celastrol